SPDR S&P Biotech ETF $XBI Shares Purchased by Sigma Planning Corp

Sigma Planning Corp increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 525.7% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 13,077 shares of the exchange traded fund’s stock after purchasing an additional 10,987 shares during the period. Sigma Planning Corp’s holdings in SPDR S&P Biotech ETF were worth $2,062,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank of America Corp DE raised its stake in SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Main Street Research LLC boosted its position in shares of SPDR S&P Biotech ETF by 57.4% in the first quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after buying an additional 206,953 shares during the period. Strs Ohio boosted its position in shares of SPDR S&P Biotech ETF by 4.9% in the first quarter. Strs Ohio now owns 410,500 shares of the exchange traded fund’s stock worth $52,433,000 after buying an additional 19,300 shares during the period. Northwestern Mutual Wealth Management Co. boosted its position in shares of SPDR S&P Biotech ETF by 145.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after buying an additional 186,314 shares during the period. Finally, Annex Advisory Services LLC grew its holdings in shares of SPDR S&P Biotech ETF by 4.6% during the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after buying an additional 11,723 shares in the last quarter.

SPDR S&P Biotech ETF Trading Up 2.9%

Shares of XBI stock opened at $154.84 on Wednesday. The company has a market capitalization of $10.80 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1-year low of $106.30 and a 1-year high of $169.89. The stock’s fifty day simple moving average is $157.04 and its 200-day simple moving average is $141.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.